Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Jenna who wrote (92217)	4/7/2000 11:47:00 AM
From: Jenna	Read Replies (1) \| Respond to of 120523

EXAR #11 from 29th watch list.. which was also once in my portfolio long since sold, has rebounded quite nicely. I know I didn't call EXAR timely, but it looks like this is still the first day of the rebound even though its already up 9. EXAR was an earnings play that exploded from 50 to 100 after earnings. Its only 63 now.. with earnings up ahead, I leave the rest to you ;-).. Are we having fun yet? when I was younger I couldn't resist a bargain.. Now I usually pay full price because I don't usually buy at stores that have sales (or I never see them) but that's only on clothes.. I will never pay full price on a stock.

To: Jenna who wrote (92217)	4/7/2000 12:18:00 PM
From: Jenna	Read Replies (1) \| Respond to of 120523

HGSI, and MYGN.. biotechs are not ready for another deep profit. I see spurts of 25-30% at most for the time being. I might be a buyer of HGSI and/or MYGN after this 'dip' today. Holding through a 30-40% gain in the biotechs will only result in 10-20% corrections in between. I would hold a few positions just to 'keep a foot in the door'.. When biotechs without earnings move 30-40% in one day or even two you are going to get profit taking.. The techs are different.. where you have earnings you don't have to separate hype from fact.. You just have facts. That is why I stayed in my techs this week but dumped the biotechs (except 2).